Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues $ 203,640 $ 6,500
Operating expenses:        
Research and development 205,503 119,345 544,235 279,640
Occupancy 10,114 7,500 27,595 7,500
Depreciation 3,152 2,715 9,147 6,731
Other operating expenses 373,769 2,836 385,365 12,094
Total operating expenses 592,538 132,396 966,342 305,965
Loss from operations (592,538) (132,396) (762,702) (299,465)
Other income (expense):        
Interest expense (4,286) (687) (10,399) (1,154)
Total other income (expense) (4,286) (687) (10,399) (1,154)
Loss before income taxes (596,824) (133,083) (773,101) (300,619)
Income tax expense
Net loss (596,824) (133,083) (773,101) (300,619)
Accretion on Series A preferred stock (397,591) (397,591)
Net loss attributed to common shareholders $ (994,415) $ (133,083) $ (1,170,692) $ (300,619)
Basic net loss per common share $ 0.00 $ 0.00 $ 0.00 $ 0.00
Diluted net loss per common share $ 0.00 $ 0.00 $ 0.00 $ 0.00
Basic weighted average common shares outstanding 415,691,123 414,000,000 414,567,822 414,000,000
Diluted weighted average common shares outstanding 415,691,123 414,000,000 414,567,822 414,000,000